Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Bonetti

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Lancet (London, England)|February 8, 2003
Hepatic artery infusion for liver metastases from colorectal cancerAndrea Bonetti
Recenti Progressi in Medicina|April 20, 2016
The development of hypertension in metastatic colorectal cancer patients treated with aflibercept: the role of systolic and diastolic blood pressure before starting treatmentJacopo Giuliani, Andrea Bonetti
Journal of Gastrointestinal Cancer|August 5, 2016
The Pharmacological Costs of Complete Liver Resections in Unselected Advanced Colorectal Cancer Patients: Focus on Targeted Agents. A Review of Randomized Clinical TrialsJacopo Giuliani, Andrea Bonetti
Expert Review of Pharmacoeconomics & Outcomes Research|June 27, 2017
Epidermal growth factor inhibitors in first-line for metastatic colorectal cancer with ras wild-type: a perspective based on pharmacological costsJacopo Giuliani, Andrea Bonetti
The Lancet Regional Health. Europe|September 24, 2021
Implications of drugs with rebate in EuropeAndrea Bonetti, Jacopo Giuliani
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|February 2, 2019
FOLFIRINOX is a cost-effective combination chemotherapy in first-line for advanced pancreatic CancerJacopo Giuliani, Andrea Bonetti
Clinical Genitourinary Cancer|December 15, 2018
Cost-Effectiveness of Second-Line Treatments for Metastatic Renal-Cell CarcinomaJacopo Giuliani, Andrea Bonetti
Recenti Progressi in Medicina|August 6, 2019
Jacopo Giuliani, Andrea Bonetti
Digestive Diseases and Sciences|June 20, 2015
Acute Liver Failure Caused by Metastatic Breast Cancer: Can We Expect Some Results from Chemotherapy?Jacopo Giuliani, Andrea Bonetti
Tumori|May 9, 2015
Trends in survival for patients with metastatic breast cancer: is survival improving?Jacopo Giuliani, Andrea Bonetti
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Lancet (London, England)|February 8, 2003
Hepatic artery infusion for liver metastases from colorectal cancerAndrea Bonetti
Recenti Progressi in Medicina|April 20, 2016
The development of hypertension in metastatic colorectal cancer patients treated with aflibercept: the role of systolic and diastolic blood pressure before starting treatmentJacopo Giuliani, Andrea Bonetti
Journal of Gastrointestinal Cancer|August 5, 2016
The Pharmacological Costs of Complete Liver Resections in Unselected Advanced Colorectal Cancer Patients: Focus on Targeted Agents. A Review of Randomized Clinical TrialsJacopo Giuliani, Andrea Bonetti
Expert Review of Pharmacoeconomics & Outcomes Research|June 27, 2017
Epidermal growth factor inhibitors in first-line for metastatic colorectal cancer with ras wild-type: a perspective based on pharmacological costsJacopo Giuliani, Andrea Bonetti
The Lancet Regional Health. Europe|September 24, 2021
Implications of drugs with rebate in EuropeAndrea Bonetti, Jacopo Giuliani
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|February 2, 2019
FOLFIRINOX is a cost-effective combination chemotherapy in first-line for advanced pancreatic CancerJacopo Giuliani, Andrea Bonetti
Clinical Genitourinary Cancer|December 15, 2018
Cost-Effectiveness of Second-Line Treatments for Metastatic Renal-Cell CarcinomaJacopo Giuliani, Andrea Bonetti
Recenti Progressi in Medicina|August 6, 2019
Jacopo Giuliani, Andrea Bonetti
Digestive Diseases and Sciences|June 20, 2015
Acute Liver Failure Caused by Metastatic Breast Cancer: Can We Expect Some Results from Chemotherapy?Jacopo Giuliani, Andrea Bonetti
Tumori|May 9, 2015
Trends in survival for patients with metastatic breast cancer: is survival improving?Jacopo Giuliani, Andrea Bonetti
Pageof 14